✦ LIBER ✦

EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone

✍ Scribed by Sheena McCormack; Wolfgang Stöhr; Tristan Barber; Pierre-Alexandre Bart; Alexandre Harari; Christiane Moog; Donatella Ciuffreda; Cristina Cellerai; Miranda Cowen; Romilda Gamboni; Séverine Burnet; Ken Legg; Elizabeth Brodnicki; Hans Wolf; Ralf Wagner; Jonathan Heeney; Marie-Joëlle Frachette; Jim Tartaglia; Abdel Babiker; Giuseppe Pantaleo; Jonathan Weber

Book ID: 116960425
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 851 KB
Volume: 26
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2008.02.072

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EV01: A phase I trial in healthy HIV neg

EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium

✍ Pierre-Alexandre Bart; Ruth Goodall; Tristan Barber; Alexandre Harari; Ana Guima 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 758 KB

Corrigendum to “DNA prime/protein boost

Corrigendum to “DNA prime/protein boost immunization against HIV clade C: Safety and immunogenicity in mice” [Vaccine 24 (2006) 2324–2332]

✍ Robert A. Rasmussen; Helena Ong; Christian Kittel; Claudia R. Ruprecht; Flavia F 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Phase I clinical trial safety of DNA- an

Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers

✍ Inese Cebere; Lucy Dorrell; Helen McShane; Alison Simmons; Sheena McCormack; Cla 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 289 KB

Lessons from IAVI-006, a Phase I clinica

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers

✍ A. Guimarães-Walker; N. Mackie; S. McCormack; T. Hanke; C. Schmidt; J. Gilmour; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 498 KB

Corrigendum to “Lessons from IAVI-006, a

Corrigendum to “Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers” [Vaccine 26 (2008) 6671–6677]

✍ A. Guimarães-Walker; N. Mackie; S. McCormack; T. Hanke; C. Schmidt; J. Gilmour; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Study to compare the efficacy and safety

Study to compare the efficacy and safety of fluconazole cream with flutrimazole cream in the treatment of superficial mycosis: a multicentre, randomised, double-blind, phase III trial

✍ S. M. Yim; J. H. Ko; Y. W. Lee; H. W. Kim; J. Y. Lee; N. I. Kim; Y. C. Kye; K. C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB